Drug Shortage Report for NOVO-GESIC
| Report ID | 87680 |
| Drug Identification Number | 00389218 |
| Brand name | NOVO-GESIC |
| Common or Proper name | GESIC |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | ACETAMINOPHEN |
| Strength(s) | 325MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 UD |
| ATC code | N02BE |
| ATC description | OTHER ANALGESICS AND ANTIPYRETICS |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | |
| Actual start date | 2019-06-15 |
| Estimated end date | |
| Actual end date | 2020-03-18 |
| Shortage status | Resolved |
| Updated date | 2020-03-19 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v11 | 2020-03-19 | French | Compare |
| v10 | 2020-03-19 | English | Compare |
| v9 | 2019-09-19 | French | Compare |
| v8 | 2019-09-19 | English | Compare |
| v7 | 2019-08-22 | French | Compare |
| v6 | 2019-08-22 | English | Compare |
| v5 | 2019-08-06 | French | Compare |
| v4 | 2019-08-06 | English | Compare |
| v3 | 2019-06-27 | French | Compare |
| v2 | 2019-06-27 | English | Compare |
| v1 | 2019-06-27 | English | Compare |
Showing 1 to 11 of 11